Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 221

    1.

    Comparison of site-reported and core laboratory-reported creatine kinase-MB values in non-ST-segment elevation acute coronary syndrome (from the international trial SYNERGY).

    Linefsky JP, Lin M, Pieper KS, Reist CJ, Berdan LG, Antman EM, Goodman SG, French JK, Guneri S, Roe MT, Newby LK, Harrington RA, Ferguson JJ, Califf RM, Mahaffey KW.

    Am J Cardiol. 2009 Nov 15;104(10):1330-5. Epub 2009 Sep 25.PMID: 19892046 [PubMed - in process]Related articles

    2.

    Practice patterns, outcomes, and end-organ dysfunction for patients with acute severe hypertension: the Studying the Treatment of Acute hyperTension (STAT) registry.

    Katz JN, Gore JM, Amin A, Anderson FA, Dasta JF, Ferguson JJ, Kleinschmidt K, Mayer SA, Multz AS, Peacock WF, Peterson E, Pollack C, Sung GY, Shorr A, Varon J, Wyman A, Emery LA, Granger CB; STAT Investigators.

    Am Heart J. 2009 Oct;158(4):599-606.e1.PMID: 19781420 [PubMed - indexed for MEDLINE]Related articles

    3.

    Antithrombotics in acute coronary syndromes.

    Bonaca MP, Steg PG, Feldman LJ, Canales JF, Ferguson JJ, Wallentin L, Califf RM, Harrington RA, Giugliano RP.

    J Am Coll Cardiol. 2009 Sep 8;54(11):969-84. Review.PMID: 19729112 [PubMed - indexed for MEDLINE]Related articles

    4.

    Prevalence, predictors, and impact of conservative medical management for patients with non-ST-segment elevation acute coronary syndromes who have angiographically documented significant coronary disease.

    Chan MY, Mahaffey KW, Sun LJ, Pieper KS, White HD, Aylward PE, Ferguson JJ, Califf RM, Roe MT.

    JACC Cardiovasc Interv. 2008 Aug;1(4):369-78. Erratum in: JACC Cardiovasc Interv. 2008 Oct;1(5):600-1. PMID: 19463332 [PubMed - indexed for MEDLINE]Related articles

    5.

    Safety of enoxaparin versus unfractionated heparin during percutaneous coronary intervention.

    Díez JG, Medina HM, Cheong BY, O'Meallie L, Ferguson JJ.

    Tex Heart Inst J. 2009;36(2):98-103.PMID: 19436801 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Relationship between renal function and outcomes in high-risk patients with non-ST-segment elevation acute coronary syndromes: Results from SYNERGY.

    Spinler SA, Mahaffey KW, Gallup D, Levine GN, Ferguson JJ 3rd, Rao SV, Gallo R, Ducas J, Goodman SG, Antman E, White HD, Biasucci L, Becker RC, Col JJ, Cohen M, Harrington RA, Califf RM; for the SYNERGY Trial Investigators.

    Int J Cardiol. 2009 Apr 28. [Epub ahead of print]PMID: 19406493 [PubMed - as supplied by publisher]Related articles

    7.

    Antiplatelet 'resistance' and 'non-responders': what do these terms really mean?

    Serebruany VL, Eisert C, Atar D, Ferguson JJ.

    Fundam Clin Pharmacol. 2009 Feb;23(1):11-8. Review.PMID: 19267767 [PubMed - indexed for MEDLINE]Related articles

    9.

    Obesity in patients with non-ST-segment elevation acute coronary syndromes: Results from the SYNERGY trial.

    Mahaffey KW, Tonev ST, Spinler SA, Levine GN, Gallo R, Ducas J, Goodman SG, Antman EM, Becker RC, Langer A, White HD, Aylward PE, Col JJ, Ferguson JJ, Califf RM; on behalf of the SYNERGY Trial Investigators.

    Int J Cardiol. 2008 Nov 13. [Epub ahead of print]PMID: 19012977 [PubMed - as supplied by publisher]Related articles

    10.

    Smoking status and antithrombin therapy in patients with non-ST-segment elevation acute coronary syndrome.

    Leung S, Gallup D, Mahaffey KW, Cohen M, Antman EM, Goodman SG, Harrington RA, Langer A, Aylward P, Ferguson JJ, Califf RM; SYNERGY Trial Investigators.

    Am Heart J. 2008 Jul;156(1):177-84. Epub 2008 Apr 3.PMID: 18585514 [PubMed - indexed for MEDLINE]Related articles

    11.

    Bleeding risks of combination vs. single antiplatelet therapy: a meta-analysis of 18 randomized trials comprising 129,314 patients.

    Serebruany VL, Malinin AI, Ferguson JJ, Vahabi J, Atar D, Hennekens CH.

    Fundam Clin Pharmacol. 2008 Jun;22(3):315-21.PMID: 18485150 [PubMed - indexed for MEDLINE]Related articles

    12.

    Coronary artery bypass surgery in patients with acute coronary syndromes is difficult to predict.

    Chew DP, Mahaffey KW, White HD, Huang Z, Hoekstra JW, Ferguson JJ, Califf RM, Aylward PE.

    Am Heart J. 2008 May;155(5):841-7. Epub 2008 Feb 21.PMID: 18440330 [PubMed - indexed for MEDLINE]Related articles

    13.

    A word from the dark side.

    Ferguson JJ.

    Tex Heart Inst J. 2008;35(1):1. No abstract available. PMID: 18427641 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Use of Enoxaparin in Patients Undergoing Percutaneous Coronary Intervention.

    Kadakia RA, Ferguson JJ.

    Crit Pathw Cardiol. 2003 Mar;2(1):1-6.PMID: 18340312 [PubMed - as supplied by publisher]Related articles

    15.

    Assessing the Effect of Publication of Clinical Guidelines on the Management of Unstable Angina and Non-ST Elevation Myocardial Infarction in The TIMI III (1990-1993) and the GUARANTEE (1995-1996) Registries.

    Scirica BM, Cannon CP, Gibson CM, Murphy SA, Moliterno DJ, Anderson HV, Aguirre FV, Granger CB, Lambrew CT, Rabbani LE, Sapp SK, Booth JE, Ferguson JJ, Braunwald E.

    Crit Pathw Cardiol. 2002 Sep;1(3):150-158.PMID: 18340298 [PubMed - as supplied by publisher]Related articles

    16.

    Low-molecular-weight heparins : mechanisms, trials, and role in contemporary interventional medicine.

    Canales JF, Ferguson JJ.

    Am J Cardiovasc Drugs. 2008;8(1):15-25. Review.PMID: 18303934 [PubMed - indexed for MEDLINE]Related articles

    17.

    Patients with non-ST-elevation acute coronary syndromes undergoing coronary artery bypass grafting in the modern era of antithrombotic therapy.

    Chew DP, Huang Z, Pieper KS, White H, Mahaffey KW, Ferguson JJ, Califf RM, Aylward PG.

    Am Heart J. 2008 Feb;155(2):239-44. Epub 2007 Nov 26.PMID: 18215592 [PubMed - indexed for MEDLINE]Related articles

    18.

    Prediction of one-year survival in high-risk patients with acute coronary syndromes: results from the SYNERGY trial.

    Mahaffey KW, Yang Q, Pieper KS, Antman EM, White HD, Goodman SG, Cohen M, Kleiman NS, Langer A, Aylward PE, Col JJ, Reist C, Ferguson JJ, Califf RM; SYNERGY Trial Investigators.

    J Gen Intern Med. 2008 Mar;23(3):310-6. Epub 2008 Jan 15.PMID: 18196350 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Pharmacoinvasive management of acute coronary syndrome: incorporating the 2007 ACC/AHA guidelines: the CATH (cardiac catheterization and antithrombotic therapy in the hospital) Clinical Consensus Panel Report--III.

    Cohen M, Diez JE, Levine GN, Ferguson JJ 3rd, Morrow DA, Rao SV, Zidar JP; ACC; AHA.

    J Invasive Cardiol. 2007 Dec;19(12):525-38; quiz 539-40. Review.PMID: 18180524 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Time to coronary angiography and outcomes among patients with high-risk non ST-segment elevation acute coronary syndromes: results from the SYNERGY trial.

    Tricoci P, Lokhnygina Y, Berdan LG, Steinhubl SR, Gulba DC, White HD, Kleiman NS, Aylward PE, Langer A, Califf RM, Ferguson JJ, Antman EM, Newby LK, Harrington RA, Goodman SG, Mahaffey KW.

    Circulation. 2007 Dec 4;116(23):2669-77. Epub 2007 Nov 19.PMID: 18025532 [PubMed - indexed for MEDLINE]Related articlesFree article

    21.

    Antithrombotic therapy and the transition to the catheterization laboratory in UA/NSTEMI.

    Ferguson JJ, Wilson JM, Diez J.

    Minerva Cardioangiol. 2007 Oct;55(5):529-56. Review.PMID: 17912162 [PubMed - indexed for MEDLINE]Related articles

    22.

    Of Swiss alchemists and road hazards.

    Ferguson JJ, Tom CW.

    J Invasive Cardiol. 2007 Oct;19(10):437-8. No abstract available. PMID: 17906346 [PubMed - indexed for MEDLINE]Related articlesFree article

    23.

    Assessing risk after acute myocardial infarction.

    Idelchik GM, Steinberg DH, Ferguson JJ, Waksman R.

    J Am Coll Cardiol. 2007 Jun 5;49(22):2227; author reply 2227-8. Epub 2007 May 23. No abstract available. PMID: 17543647 [PubMed - indexed for MEDLINE]Related articles

    24.

    Treatment and outcomes of patients with evolving myocardial infarction: experiences from the SYNERGY trial.

    Miller CD, Banerjee A, Mahaffey KW, Kontos MC, Fermann G, Pollack CV Jr, Antman E, Aylward P, Goodman SG, Santos R, Ferguson JJ, Califf RM, Hoekstra JW.

    Eur Heart J. 2007 May;28(9):1079-84. Epub 2007 Apr 3.PMID: 17405770 [PubMed - indexed for MEDLINE]Related articlesFree article

    25.

    Racial differences among high-risk patients presenting with non-ST-segment elevation acute coronary syndromes (results from the SYNERGY trial).

    Echols MR, Mahaffey KW, Banerjee A, Pieper KS, Stebbins A, Lansky A, Cohen MG, Velazquez E, Santos R, Newby LK, Gurfinkel EP, Biasucci L, Ferguson JJ, Califf RM.

    Am J Cardiol. 2007 Feb 1;99(3):315-21. Epub 2006 Nov 30.PMID: 17261389 [PubMed - indexed for MEDLINE]Related articles

    26.

    Strategies for optimizing outcomes in the NSTE-ACS patient The CATH (cardiac catheterization and antithrombotic therapy in the hospital) Clinical Consensus Panel Report.

    Cohen M, Diez J, Fry E, Rao SV, Ferguson JJ 3rd, Zidar J, Levine G, Shani J.

    J Invasive Cardiol. 2006 Dec;18(12):617-39.PMID: 17197714 [PubMed - indexed for MEDLINE]Related articles

    27.

    Efficacy and safety of enoxaparin compared with unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention in the Superior Yield of the New Strategy of Enoxaparin, Revascularization and Glycoprotein IIb/IIIa Inhibitors (SYNERGY) trial.

    White HD, Kleiman NS, Mahaffey KW, Lokhnygina Y, Pieper KS, Chiswell K, Cohen M, Harrington RA, Chew DP, Petersen JL, Berdan LG, Aylward PE, Nessel CC, Ferguson JJ 3rd, Califf RM.

    Am Heart J. 2006 Dec;152(6):1042-50. Erratum in: Am Heart J. 2007 Feb;153(2):327. PMID: 17161049 [PubMed - indexed for MEDLINE]Related articles

    28.

    Bleeding complications in patients with acute coronary syndrome undergoing early invasive management can be reduced with radial access, smaller sheath sizes, and timely sheath removal.

    Cantor WJ, Mahaffey KW, Huang Z, Das P, Gulba DC, Glezer S, Gallo R, Ducas J, Cohen M, Antman EM, Langer A, Kleiman NS, White HD, Chisholm RJ, Harrington RA, Ferguson JJ, Califf RM, Goodman SG.

    Catheter Cardiovasc Interv. 2007 Jan;69(1):73-83.PMID: 17139670 [PubMed - indexed for MEDLINE]Related articles

    29.

    A subgroup analysis of the impact of prerandomization antithrombin therapy on outcomes in the SYNERGY trial: enoxaparin versus unfractionated heparin in non-ST-segment elevation acute coronary syndromes.

    Cohen M, Mahaffey KW, Pieper K, Pollack CV Jr, Antman EM, Hoekstra J, Goodman SG, Langer A, Col JJ, White HD, Califf RM, Ferguson JJ; SYNERGY Trial Investigators.

    J Am Coll Cardiol. 2006 Oct 3;48(7):1346-54. Epub 2006 Sep 12.PMID: 17010793 [PubMed - indexed for MEDLINE]Related articles

    30.

    OASIS-5: how do fondaparinux and enoxaparin compare in patients with acute coronary syndromes?

    Ferguson JJ, Idelchik GM.

    Nat Clin Pract Cardiovasc Med. 2006 Sep;3(9):474-5. No abstract available. PMID: 16932761 [PubMed]Related articles

    31.

    The role of oral antiplatelet agents in atherothrombotic disease.

    Ferguson JJ.

    Am J Cardiovasc Drugs. 2006;6(3):149-57. Review.PMID: 16780388 [PubMed - indexed for MEDLINE]Related articles

    32.

    High-risk patients with acute coronary syndromes treated with low-molecular-weight or unfractionated heparin: outcomes at 6 months and 1 year in the SYNERGY trial.

    Mahaffey KW, Cohen M, Garg J, Antman E, Kleiman NS, Goodman SG, Berdan LG, Reist CJ, Langer A, White HD, Aylward PE, Col JJ, Ferguson JJ 3rd, Califf RM; SYNERGY Trial Investigators.

    JAMA. 2005 Nov 23;294(20):2594-600.PMID: 16304073 [PubMed - indexed for MEDLINE]Related articlesFree article

    33.

    Noncompliance in cardiovascular clinical trials.

    Serebruany VL, Oshrine BR, Malinin AI, Atar D, Michelson AD, Ferguson JJ 3rd.

    Am Heart J. 2005 Nov;150(5):882-6. Review. No abstract available. PMID: 16290953 [PubMed - indexed for MEDLINE]Related articles

    34.

    Utilization of catheterization and revascularization procedures in patients with non-ST segment elevation acute coronary syndrome over the last decade.

    Levine GN, Lincoff AM, Ferguson JJ 3rd, Mahaffey KW, Goodman SG, Cannon CP, Theroux P, Fox KA.

    Catheter Cardiovasc Interv. 2005 Oct;66(2):149-57.PMID: 16152646 [PubMed - indexed for MEDLINE]Related articles

    35.

    Clopidogrel plus aspirin in patients with acute myocardial infarction treated with fibrinolytic therapy - CLARITY-TIMI 28.

    Ferguson JJ.

    Future Cardiol. 2005 Sep;1(5):605-10.PMID: 19804099 [PubMed - in process]

    36.

    A perspective on trials comparing enoxaparin and unfractionated heparin in the treatment of non-ST-elevation acute coronary syndromes.

    Califf RM, Petersen JL, Hasselblad V, Mahaffey KW, Ferguson JJ.

    Am Heart J. 2005 Apr;149(4 Suppl):S91-9.PMID: 16124953 [PubMed - indexed for MEDLINE]Related articles

    37.

    Exploring the role of enoxaparin in the management of high-risk patients with non-ST-elevation acute coronary syndromes: the SYNERGY trial.

    Mahaffey KW, Ferguson JJ.

    Am Heart J. 2005 Apr;149(4 Suppl):S81-90.PMID: 16124952 [PubMed - indexed for MEDLINE]Related articles

    38.

    2004: that was the year that was.

    Ferguson JJ 3rd.

    Tex Heart Inst J. 2005;32(1):2-6. No abstract available. PMID: 15902813 [PubMed - indexed for MEDLINE]Related articlesFree article

    39.

    Direct stenting and placement of a distal protection device after laser angioplasty in a saphenous vein graft with severe stenosis.

    Kohsaka S, Ferguson JJ, Hernandez-Vila E.

    J Invasive Cardiol. 2005 Mar;17(3):160-2. No abstract available. PMID: 15867446 [PubMed - indexed for MEDLINE]Related articles

    40.

    Optimal antithrombotic treatment for percutaneous coronary intervention.

    Kadakia RA, Ferguson JJ.

    Minerva Cardioangiol. 2005 Feb;53(1):15-42. Review.PMID: 15788977 [PubMed - indexed for MEDLINE]Related articlesFree article

    41.

    Retroactive indexing: the apotheosis of a laboratory bulletin?

    Ferguson JJ 3rd.

    Tex Heart Inst J. 2004;31(3):205. No abstract available. PMID: 15562835 [PubMed - indexed for MEDLINE]Related articlesFree article

    42.

    Coordinated series of studies to evaluate characteristics and mechanisms of acute coronary syndromes in high-risk patients randomly assigned to enoxaparin or unfractionated heparin: design and rationale of the SYNERGY Library.

    Petersen JL, Mahaffey KW, Becker RC, Goodman SG, Kleiman NS, Marian AJ, Stone GW, Lansky AJ, Lincoff AM, Hazen SL, Nessel CC, Toro-Figueroa L, Tate L, Reist CJ, Cohen M, Califf RM, Ferguson JJ; SYNERGY Library.

    Am Heart J. 2004 Aug;148(2):269-76.PMID: 15308996 [PubMed - indexed for MEDLINE]Related articles

    43.

    Angiography and interventional cardiology.

    Ferguson JJ, Douglas JS, Holmes DR, Roubin GS, Smith KM.

    J Am Coll Cardiol. 2004 Jul 21;44(2 Suppl A):13A-15A. No abstract available. PMID: 15261684 [PubMed - indexed for MEDLINE]Related articles

    44.

    In-hospital mortality associated with the use of intra-aortic balloon counterpulsation.

    Urban PM, Freedman RJ, Ohman EM, Stone GW, Christenson JT, Cohen M, Miller MF, Joseph DL, Bynum DZ, Ferguson JJ 3rd; Benchmark Registry Investigators.

    Am J Cardiol. 2004 Jul 15;94(2):181-5.PMID: 15246896 [PubMed - indexed for MEDLINE]Related articles

    45.

    Efficacy and bleeding complications among patients randomized to enoxaparin or unfractionated heparin for antithrombin therapy in non-ST-Segment elevation acute coronary syndromes: a systematic overview.

    Petersen JL, Mahaffey KW, Hasselblad V, Antman EM, Cohen M, Goodman SG, Langer A, Blazing MA, Le-Moigne-Amrani A, de Lemos JA, Nessel CC, Harrington RA, Ferguson JJ, Braunwald E, Califf RM.

    JAMA. 2004 Jul 7;292(1):89-96. Review.PMID: 15238596 [PubMed - indexed for MEDLINE]Related articlesFree article

    46.

    Enoxaparin vs unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes managed with an intended early invasive strategy: primary results of the SYNERGY randomized trial.

    Ferguson JJ, Califf RM, Antman EM, Cohen M, Grines CL, Goodman S, Kereiakes DJ, Langer A, Mahaffey KW, Nessel CC, Armstrong PW, Avezum A, Aylward P, Becker RC, Biasucci L, Borzak S, Col J, Frey MJ, Fry E, Gulba DC, Guneri S, Gurfinkel E, Harrington R, Hochman JS, Kleiman NS, Leon MB, Lopez-Sendon JL, Pepine CJ, Ruzyllo W, Steinhubl SR, Teirstein PS, Toro-Figueroa L, White H; SYNERGY Trial Investigators.

    JAMA. 2004 Jul 7;292(1):45-54.PMID: 15238590 [PubMed - indexed for MEDLINE]Related articlesFree article

    47.

    Noncompliance in antiplatelet trials: the AGATE trial perspective.

    Serebruany VL, Hanley DF Jr, Atar D, Ferguson JJ.

    Stroke. 2004 Jun;35(6):e143. Epub 2004 Apr 15. No abstract available. PMID: 15087566 [PubMed - indexed for MEDLINE]Related articlesFree article

    48.

    Symposium on 'influencing prescribing', Trinity College Dublin, Friday 20 June 1997.

    Ferguson JJ.

    Pharmacoepidemiol Drug Saf. 1998 Sep;7(5):339-43. No abstract available. PMID: 15073981 [PubMed]Related articles

    49.

    Low-molecular-weight heparins in the cardiac catheterization laboratory.

    Kadakia RA, Baimeedi SR, Ferguson JJ.

    Tex Heart Inst J. 2004;31(1):72-83. Review.PMID: 15061631 [PubMed - indexed for MEDLINE]Related articlesFree article

    50.

    If there's smoke, is there fire?

    Ferguson JJ.

    Circulation. 2004 Mar 30;109(12):1442-4. No abstract available. PMID: 15051646 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data

    Search details

    » See more...